Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Robust Association Between Migraine and Sleep Apnea

Published: Mon, 26 Jun 2017 08:55:50 EDT
Results from the CaMEO study suggest that if migraine and sleep apnea are linked, then treating the apnea might reduce headache frequency.
Medscape Medical News

Siponimod Effective, Safe in Secondary Progressive MS

Published: Mon, 26 Jun 2017 07:49:06 EDT
EXPAND trial results show that the selective S1P receptor modulator reduced the risk for confirmed disability progression by 21% at 3 months and 26% at 6 months and was safe.
Medscape Medical News

EMA Panel Likes Breast and Kidney Cancer Drugs

Published: Mon, 26 Jun 2017 05:27:17 EDT
The Committee for Medicinal Products for Human Use recommended approval of ribociclib for advanced HER+/HER2- breast cancer and tivozanib for advanced renal cell carcinoma.
International Approvals

Modifiable Risk Factors and Preoperative Optimization in THA

Published: Mon, 26 Jun 2017 12:00:00 EDT
An understanding of the modifiable preoperative risk factors will help reduce the risk of complications and optimize outcomes in total hip arthroplasty.
Current Orthopaedic Practice
Displaying results 9-12 (of 20)
 1 - 2 - 3 - 4 - 5 


Biotech bounces as the bones of Trump's plans on pricing emerge

Published: Thu, 22 Jun 2017 12:59:20 +0000
Biotech stocks are enjoying their most buoyant patch in months, with three straight days of solid gains on reports that President Donald Trump's threatened crackdown on pricing may not be as tough as feared.

Seven years after Merck deal, ElexoPharm offloads aldosterone synthase inhibitors to Angion

Published: Thu, 22 Jun 2017 12:19:15 +0000
ElexoPharm has licensed inhibitors of the aldosterone synthase enzyme to Angion Biomedica. The exclusive pact comes seven years after ElexoPharm struck a deal granting Merck rights to drugs against the same target.

Eli Lilly completes expansion of San Diego biotech center

Published: Thu, 22 Jun 2017 09:54:06 +0000
Eli Lilly has completed the expansion of its biotech facility in San Diego, California. The Big Pharma has more than doubled the size of the West Coast site and installed an automated, remote-controlled drug design and testing studio. 

Celgene-backed cancer biotech Repare emerges from stealth with $68M

Published: Thu, 22 Jun 2017 08:16:06 +0000
After 18 months being incubated by Versant Ventures, upstart Repare Therapeutics has emerged from stealth mode with an impressive $68 million.
Displaying results 9-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy